Legal Briefs: September Is a Mixed Bag For Brand Pharma Patents
Former InterMune CEO convicted of wire fraud for misleading press release: A California jury convicted W. Scott Harkonen of wire fraud for the creation and dissemination of false and misleading information about the efficacy of InterMune's Actimmune (interferon gamma-1b) as a treatment for idiopathic pulmonary fibrosis. The information was included in a press release the company issued in 2002 announcing the results of a clinical trial. The jury acquitted him of a misbranding charge of promoting the drug for an unapproved use. A grand jury indicted Harkonen for fraudulent promotion in 2008, two years after InterMune entered a deferred prosecution agreement with the Department of Justice and agreed to pay $36.9 million to resolve criminal charges and civil liabilities for fraudulent promotion (1"The Pink Sheet" DAILY, March 18, 2008). The government has prosecuted pharma execs in the past but has largely been unsuccessful in winning verdicts against them. Eight executives of TAP were acquitted in a 2001 case over pricing and marketing of the prostate cancer drug Lupron (leuprolide) and several Serono executives were acquitted in a case over marketing of the AIDS drug Serostim (somatropin) (2"The Pink Sheet," March 31, 2008)
Learn what's happening at the US FDA. On the go.
More from Archive
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
More from Pink Sheet
Revised recommendation is based on most recent data on circulating strains in US, where KP.3 is now dominant. Novavax sticks with plans targeting the JN.1 ‘parent strain.’
Pink Sheet reporter and editors discuss the US FDA’s changes to the COVID-19 vaccine indication and its revocation of the vaccine emergency use authorizations, as well as new vaccine coverage and reimbursement questions.
To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.